Country: New Zealand
Bahasa: Inggeris
Sumber: Medsafe (Medicines Safety Authority)
Lumiracoxib 400mg (release testing to occur at Novartis AG, Lichstrasse, Basel.)
Novartis New Zealand Ltd
Lumiracoxib 400 mg (release testing to occur at Novartis AG, Lichstrasse, Basel.)
400 mg
Film coated tablet
Active: Lumiracoxib 400mg (release testing to occur at Novartis AG, Lichstrasse, Basel.) Excipient: Croscarmellose sodium 00F17713 Basic coating premix black Magnesium stearate Microcrystalline cellulose Opadry Opadry white 00F18296 Povidone
Blister pack, PVC/Al x 2 tablets sample pack, 2 tablets
Prescription
Prescription
Novartis Grimsby Limited
Package - Contents - Shelf Life: Blister pack, PVC/Al x 2 tablets sample pack - 2 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 5 tablets - 5 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 10 tablets - 10 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 20 tablets - 20 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 30 tablets - 30 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 50 tablets - 50 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, PVC/Al x 100 tablets - 100 tablets - 36 months from date of manufacture stored at or below 30°C
2003-01-09